FTH
Faeth Therapeutics, Inc.
24.90$
-7.3%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -59.3% | +145.2% | – | – | -0.3% | -89.7% | +8.8% | -8.1% | +0.0% | -11.8% | -20.0% | – | |
| – | +4.8% | +10.7% | -34.6% | -7.8% | -46.7% | +17.9% | -42.7% | -3.8% | +16.1% | +4,272.2% | -65.2% | – | |
| – | -140.9% | – | – | +609.4% | -58.5% | -443.6% | – | – | -39.0% | +4,557.3% | -126.4% | – | |
| – | – | – | +194.6% | -100.0% | – | – | – | -100.0% | – | – | +0.0% | – | |
| – | -0.6% | -30.2% | +19.7% | +87.0% | -124.4% | – | +21.8% | -80.1% | +19.4% | -1,610.6% | +243.8% | – | |
| – | -89.2% | -96.0% | – | – | – | – | – | -100.0% | – | – | -88.4% | – | |
| – | – | – | – | – | – | – | -18.5% | -11.6% | -25.7% | -45.1% | -71.0% | – | |
| – | -83.0% | -51.5% | -13.9% | +13.3% | -4.9% | +10.3% | -21.5% | -9.5% | -27.0% | – | -100.9% | – | |
| – | +49.3% | -223.2% | – | +674.3% | -226.2% | – | – | -174.4% | – | – | -187.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.